FDAnews Device Daily Bulletin

April 11, 2012 | Vol. 9 No. 72

FDA Panel Sets Date To Review Sapien for High-Risk Cohort

The FDA’s advisory panel has proposed a review of Edward Lifesciences’ premarket approval (PMA) application for its Edwards Sapien transcatheter heart valve on June 13.
CardiovascularBusiness

Register Now
Print This Page
Email This Article
RSS
Archives

Health Affects Benefits of Implanted Heart Device Trove of Medical Devices Found to Have Password Problems Delcath Faces Investor Ire Following Negative FDA Panel Vote Boston Scientific Begins Patient Enrollment in U.S. Clinical Trial for Use of Vercise DBS System for Parkinson's Disease

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.